#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13548	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2048	649.0	0	.	n	.	0	C451T	SNP	451	451	C	667	667	T	789	T,C	744,13	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13548	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2048	649.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1400	1400	C	740	C	707	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	695.8	0	.	n	.	0	T695C	SNP	695	695	T	1044	1044	C	793	C	753	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	695.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2320	2320	C	794	C,G	751,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	695.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2394	2394	A	803	A	760	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	695.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2946	2946	C	779	C	740	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25490	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	695.8	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1987	1987	A	811	A,G,T	456,324,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1628	folP	855	855	100.0	folP.l15.c4.ctg.1	1562	103.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	167;167;168	A;G;C,A	161;161;161,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4506	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	129.7	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	140;140;139	T;T;C	131;131;131	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4506	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	129.7	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	138;137;136	G;G;C	129;126;127	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4506	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	129.7	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	138;137;136	G;G;C	129;126;127	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1412	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1238	111.8	1	SNP	p	G45D	0	.	.	133	135	GGC	453	455	GGC	183;180;181	G;G;C	173;170;172	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	708	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1061	66.2	0	.	n	.	0	A197.	DEL	197	197	A	574	574	A	156	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4730	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	163.2	1	SNP	p	D86N	0	.	.	256	258	GAC	528	530	GAC	184;184;188	G;A,C;C	180;172,1;183	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4730	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	163.2	1	SNP	p	R87I	0	.	.	259	261	CGT	531	533	CGT	189;188;192	C;G,A;T	184;180,1;183	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4730	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	163.2	1	SNP	p	S87R	1	.	.	259	261	CGT	531	533	CGT	189;188;192	C;G,A;T	184;180,1;183	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4730	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	163.2	1	SNP	p	R87W	0	.	.	259	261	CGT	531	533	CGT	189;188;192	C;G,A;T	184;180,1;183	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4730	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	163.2	1	SNP	p	S88P	0	.	.	262	264	TCC	534	536	TCC	191;190;190	T;C;C	184;184;183	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3356	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2583	127.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	184;182;178	G;G;C	174;171;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1184	1186	GCC	189;192;192	G;C;C	184;184;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1187	1189	ATG	193;193;193	A,G;T;G	186,1;183;184	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1199	1201	ACC	190;190;194	A;C;C,A	174;181;185,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1199	1201	ACC	190;190;194	A;C;C,A	174;181;185,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1700	1702	ACC	165;165;166	A,T;C;C	150,1;154;156	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1754	1756	GCG	143;143;146	G;C;G	139;139;143	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1754	1756	GCG	143;143;146	G;C;G	139;139;143	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1877	1879	GGT	138;135;136	G,A;G;T,C	128,1;126;123,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1886	1888	AGC	129;129;124	A,G;G;C	119,1;118;119	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3636	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2258	157.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1904	1906	CCG	108;109;105	C,G;C;G	94,3;95;85	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5330	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3088	169.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1563	1565	CCG	191;193;191	C,G;C;G	173,1;181;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2114	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1676	123.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	563	563	C	146	C,G	139,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	0	.	p	.	0	G210R	NONSYN	628	630	GGA	913	915	AGA	208;209;208	A,G;G;A	194,2;196;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	934	936	GGT	210;211;210	G,A;G;T	200,2;205;197	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1039	1041	GAA	208;209;209	G;A,G;A	199;198,3;202	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	1	SNP	p	G120K	1	.	.	358	360	AAG	643	645	AAG	226;222;221	A;A;G	218;214;210	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	1	SNP	p	A121N	1	.	.	361	363	AAC	646	648	AAC	222;225;227	A,G;A;C	213,3;218;218	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2628	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1524	169.0	1	SNP	p	N121D	0	.	.	361	363	AAC	646	648	AAC	222;225;227	A,G;A;C	213,3;218;218	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9240	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4888	186.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	936	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1101	84.0	1	SNP	p	V57M	1	.	.	169	171	ATG	593	595	ATG	185;187;188	A;T;G	181;179;181	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
